Ryan Zeidan
Chief Executive Officer at Sling Therapeutics, Inc.
Profile
Ryan Zeidan is currently the President, Chief Executive Officer & Director at Sling Therapeutics, Inc. Prior to this, he worked as the Chief Development Officer at Millendo Therapeutics, Inc. from 2019 to 2021.
He completed his undergraduate degree at the Massachusetts Institute of Technology and his doctorate at the California Institute of Technology.
Ryan Zeidan active positions
| Companies | Position | Start |
|---|---|---|
Sling Therapeutics, Inc.
 Sling Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sling Therapeutics, Inc. is a company dedicated to developing impactful and high-quality clinical therapies for patients. Sling Therapeutics is located in Ann Arbor, MI and was founded by Gary D. Hammer. The company's pipeline includes linsitinib, an oral therapy being developed for thyroid eye disease (TED) that has established a safety profile through treatment of over 800 patients. The company is focused on bringing additional treatment options to patients, as well as the ophthalmology, endocrinology, and rare disease communities. Sling Therapeutics welcomes collaboration in this mission. The CEO is Ryan Zeidan. | Chief Executive Officer | - |
Former positions of Ryan Zeidan
| Companies | Position | End |
|---|---|---|
| MILLENDO THERAPEUTICS | Corporate Officer/Principal | 28/01/2021 |
Training of Ryan Zeidan
| California Institute of Technology | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
Sling Therapeutics, Inc.
Sling Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sling Therapeutics, Inc. is a company dedicated to developing impactful and high-quality clinical therapies for patients. Sling Therapeutics is located in Ann Arbor, MI and was founded by Gary D. Hammer. The company's pipeline includes linsitinib, an oral therapy being developed for thyroid eye disease (TED) that has established a safety profile through treatment of over 800 patients. The company is focused on bringing additional treatment options to patients, as well as the ophthalmology, endocrinology, and rare disease communities. Sling Therapeutics welcomes collaboration in this mission. The CEO is Ryan Zeidan. | Commercial Services |
- Stock Market
- Insiders
- Ryan Zeidan
